Alto Ingredients, Inc. ALTO
3.73
(0.01)
(0.27%)
as of 25 Sep
- Market cap
- $290.1M
- P/E
- 5.5×
Follow ALTO
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 16.94 | 12.74 | 8.38 |
P/S ratio |
0.09 | 0.23 | 0.40 | 0.46 | |
P/FCF ratio |
0.00 | 24.81 | 11.79 | 8.63 | |
P/Operating CF |
3.54 | 22.49 | 86.00 | 15.13 | |
P/B ratio |
0.36 | 0.88 | 1.45 | 1.66 | |
Price to Tangible BV |
0.38 | 0.90 | 1.49 | 1.71 | |
EV/Sales |
0.16 | 0.29 | 0.46 | 0.51 | |
EV/EBITDA |
0.00 | 7.79 | 9.18 | 7.64 | |
EV/Operating CF |
(24.43) | 20.23 | 11.83 | 7.38 | |
EV/FCF |
(14.85) | 30.99 | 13.75 | 9.61 | |
Quick Ratio |
2.16 | 1.38 | 2.14 | 1.91 | |
Current Ratio |
3.56 | 2.64 | 3.81 | 3.19 | |
Net Debt/EBITDA |
2.69 | 3.74 | 4.67 | 2.08 | |
Debt/Assets |
25.90% | 20.48% | 18.91% | 15.23% | |
Debt/Equity |
0.45 | 0.32 | 0.29 | 0.23 | |
Asset Turnover |
2.29 | 2.32 | 2.32 | 2.39 | |
Operating CF/Net income |
1.64 | 0.44 | 1.06 | 2.50 | |
Capex/Depreciation |
(0.24) | (0.29) | (0.13) | (1.53) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.70% | 2.96% | 2.98% | 3.26% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.29% | 0.36% | 0.31% | 0.33% | |
Graham Net Nets |
(0.19) | 0.06 | 0.06 | 0.05 | |
Graham Number |
0.00 | 3.55 | 5.34 | 7.25 | |
Earnings Yield |
(63.89%) | 5.90% | 7.85% | 11.93% | |
Free Cash Flow Yield |
(12.40%) | 4.03% | 8.48% | 11.59% | |
Revenue per Share |
3.22 | 3.11 | 3.00 | 3.25 | |
Operating CF per Share |
0.30 | 0.13 | 0.06 | 0.38 | |
Capex per Share |
(0.02) | (0.03) | (0.01) | (0.14) | |
Free Cash Flow per Share |
0.28 | 0.10 | 0.04 | 0.24 | |
Cash per Share |
0.49 | 0.35 | 0.39 | 0.37 | |
Shareholders Equity per Share |
2.97 | 3.29 | 3.34 | 3.44 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.97 | 3.29 | 3.34 | 3.44 | |
Free Cash Flow |
21.15 | 7.59 | 3.30 | 17.90 | |
Working Capital |
108.50 | 96.85 | 116.90 | 110.43 | |
Capital Expenditures |
(1.63) | (1.95) | (0.91) | (10.58) | |
Net Current Asset Value |
(15.15) | 12.37 | 22.14 | 23.63 | |
EV/EBIT |
0.00 | 36.40 | 22.36 | 13.47 | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.04 | |
Net Profit Margin |
5.76% | 9.26% | 1.76% | 4.63% | |
Price to Operating Income |
0.00 | 29.15 | 19.17 | 12.10 | |
| Other line items | |||||
Average Receivables |
53.40 | 56.64 | 62.58 | 62.67 | |
Average Payables |
16.36 | 17.44 | 18.17 | 19.96 | |
Average Inventory |
50.70 | 55.80 | 51.72 | 52.74 | |
Average Assets |
402.94 | 395.11 | 394.25 | 395.07 | |
Average Common Equity |
243.16 | 235.15 | 231.90 | 233.86 |
Columns are period end dates